These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 6325112)

  • 21. The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.
    Tascilar M; Skinner HG; Rosty C; Sohn T; Wilentz RE; Offerhaus GJ; Adsay V; Abrams RA; Cameron JL; Kern SE; Yeo CJ; Hruban RH; Goggins M
    Clin Cancer Res; 2001 Dec; 7(12):4115-21. PubMed ID: 11751510
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Factors influencing long-term prognosis after pancreatoduodenectomy in cancer of the pancreas head].
    Liang XM
    Zhonghua Wai Ke Za Zhi; 1989 Apr; 27(4):211-4, 253. PubMed ID: 2553357
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Grading, staging, DNA content and prognosis of invasive ductal breast cancer].
    Theissig F; Kunze KD; Haroske G; Meyer W; Dimmer V
    Zentralbl Chir; 1990; 115(7):433-9. PubMed ID: 2164288
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nonendocrine cancer of the pancreas in patients under age forty years.
    Ivy EJ; Sarr MG; Reiman HM
    Surgery; 1990 Sep; 108(3):481-7. PubMed ID: 2168585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth hormone in vascular pathology: neovascularization and expression of receptors is associated with cellular proliferation.
    Lincoln DT; Singal PK; Al-Banaw A
    Anticancer Res; 2007; 27(6B):4201-18. PubMed ID: 18225592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states.
    Suehara N; Mizumoto K; Muta T; Tominaga Y; Shimura H; Kitajima S; Hamasaki N; Tsuneyoshi M; Tanaka M
    Clin Cancer Res; 1997 Jun; 3(6):993-8. PubMed ID: 9815776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Classification and staging of pancreatic nonendocrine tumors.
    Klöppel G; Maillet B
    Radiol Clin North Am; 1989 Jan; 27(1):105-19. PubMed ID: 2535683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Surgery for pancreatic cancer].
    Welsch T; Büchler MW; Schmidt J
    Z Gastroenterol; 2008 Dec; 46(12):1393-403. PubMed ID: 19053009
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of intraductal papillary mucinous tumours of the pancreas.
    Navarro F; Michel J; Bauret P; Ramos J; Blanc P; Fabre JM; Millat B; Desrousseaux B; Domergue J
    Eur J Surg; 1999 Jan; 165(1):43-8. PubMed ID: 10069633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of surgery in ductal carcinoma of the pancreas.
    Cangemi V; Volpino P; Mingazzini P; Fiori E; Gentili S; Ansali A; Piat G
    Int Surg; 1992; 77(3):158-63. PubMed ID: 1328103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Clinico-pathological characteristics of surgical effect on periampullary cancers: report of 631 cases].
    Shao YF; Wu TC; Shan Y; Wu JX; Wang X; Zhao P
    Zhonghua Yi Xue Za Zhi; 2005 Mar; 85(8):510-3. PubMed ID: 15949327
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas.
    Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A
    Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
    Hoorens A; Prenzel K; Lemoine NR; Klöppel G
    J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The growth pattern and microvasculature of pancreatic tumours induced with cultured carcinoma cells.
    Mäkinen K; Loimas S; Nuutinen P; Eskelinen M; Alhava E
    Br J Cancer; 2000 Feb; 82(4):900-4. PubMed ID: 10732764
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraductal papillary components in invasive ductal carcinoma of the pancreas are associated with long-term survival of patients.
    Fukushima N; Sakamoto M; Mukai K; Kanai Y; Shimada K; Kosuge T; Hirohashi S
    Hum Pathol; 2001 Aug; 32(8):834-41. PubMed ID: 11521228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Morphologic, morphometric and immunohistochemical studies on pancreatic intraductal hyperplasia and infiltrating carcinoma].
    Tomaszewska R
    Folia Med Cracov; 1999; 40(1-2):101-41. PubMed ID: 10909469
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surgical outcome of intraductal papillary mucinous neoplasms of the pancreas.
    Nakagohri T; Kinoshita T; Konishi M; Takahashi S; Gotohda N
    Ann Surg Oncol; 2007 Nov; 14(11):3174-80. PubMed ID: 17694416
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aggressive multi-visceral pancreatic resections for locally advanced neuroendocrine tumours. Is it worth it?
    Abu Hilal M; McPhail MJ; Zeidan BA; Jones CE; Johnson CD; Pearce NW
    JOP; 2009 May; 10(3):276-9. PubMed ID: 19454819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum cholecystokinin and neurotensin during follow-up of pancreas, prostate and medullary thyroid tumors.
    Pichon MF; Coquin G; Fauveau C; Rey A
    Anticancer Res; 1999; 19(2B):1445-50. PubMed ID: 10365121
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Endocrine cells in pancreatic cancers: importance for grading and prognosis?].
    Görgen-Mahler B; Saeger W; Dziwisch L
    Pathologe; 1991 Nov; 12(6):306-10. PubMed ID: 1665230
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.